These results underscore the crucial role of YAP1/AKT/GSK3β signaling in AngII-induced cardiac hypertrophy and reveal how activation of this pathway can mitigate the protective effects of LIMD1 overexpression. The gene discussed is AKT1; the disease is cardiac hypertrophy.